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The rates of nonenzymatic glucosylation of albumin, high density lipoprotein (HDL) and low density 
lipoprotein (LDL) were determined in vitro using [14C]glucose repurified by a new and rapid HPLC 
method. All commercial preparations were found to contain contaminants reacting 15-20-times faster 
with protein than the repurified [14C]glucose. Removal of contaminants was critical to the rate 
determinations and constitutes a substantial improvement over the widely used existing method. The initial 
rates of nonenzymatic glucosylation determined in vitro for albumin, HDL and LDL were used to predict 
normal in vivo levels of 0.40, 0.65 and 0.08 mol glucose per mol protein, respectively. This is within the 
range of values found in vivo for albumin and LDL, but low for HDL. These values would be expected 
to increase 2-4-fold in diabetes. 
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1. INTRODUCTION 
Attention in recent years has focused on one 
potentially deleterious consequence of the high 
glucose levels found in diabetes, the nonenzymatic 
glucosylation of proteins [ 1,2]. Proteins whose 
function is affected by glucosylated amino- 
terminal or lysine e-amino groups would be the 
most vulnerable in diabetes mellitus. There is a 
growing list of proteins which fit into this category 
including haemoglobin, collagen, lens crystallins, 
albumin, peripheral nerve protein (review [l]), 
LDL [3,4] and HDL [5]. 
The methods currently used to measure nonen- 
zymatic glucosylation were mainly devised for 
Note: nonenzymatic glucosylation is now also referred 
to as glycation 
Abbreviations: PBS, phosphate-buffered saline (pH 
7.4); HPLC, high-performance liquid chromatography; 
HDL, high density lipoprotein; LDL, low density 
lipoprotein 
haemoglobin and with the exception of chemical 
analyses [6-81 not directly applicable to other pro- 
teins. Therefore, an attractive alternative is to 
isolate the protein of interest and to explore 
glucosylation and the subsequent functional conse- 
quences in vitro. Unfortunately, monitoring incor- 
poration of 3H- or l4 C-labelled glucose has been 
flawed by the presence of radioactive con- 
taminants in all commercially available prepara- 
tions [7]. These contaminants, albeit representing 
only a few percent of the total radioactivity, react 
much more rapidly with protein than the glucose 
itself [7]. This has led to inadvertant overestima- 
tion of the rates of glucosylation [9,10] and 
possibly galactosylation [ 111. To circumvent this 
problem the radioactive glucose has been in- 
cubated with albumin for 2-3 days, followed by 
gel filtration to separate the cleansed sugar [4]. 
However, this method is time-consuming and gives 
relatively poor yields. It also relies on the probably 
erroneous assumption that all the contaminants 
are consumed during the incubation. 
We report here a rapid and convenient solution 
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to this problem. [14C]Glucose was purified by 
HPLC and was then used to follow the course of 
glucosylation of 3 plasma proteins (albumin, LDL 
and HDL) for which nonenzymatic glucosylation 
may have significant functional consequences 
[5,13,16]. The HPLC method presented here 
should also be directly applicable to the repurifica- 
tion of other radiolabelled monosaccharides. 
2. MATERIALS AND METHODS 
D-[U-14C]Glucose was purchased from the 
Radiochemical Centre (Amersham) and from the 
Commissariat a 1’Energie Atomique (CEA, Gif- 
sur-Yvette). Human serum albumin and glucose 
(puriss) were supplied by Fluka (Buchs). Bovine 
serum albumin was from Sigma (St. Louis). 
Lumagel SB and Rialuma were purchased from 
Lumac (Schaesburg). LDL and HDL were 
prepared as in [14]. 
The separation of [ 14C]glucose from “C-labelled 
contaminants was achieved by HPLC on a 4 x 
250 mm Lichrosorb NH2 column (Merck, Darm- 
stadt). Injection of the radioactive glucose, 
dissolved in either 20 or 100 ~1 water, was followed 
by isocratic elution with 1.5 ml/min acetonitrile :
water (80:20, v/v). Forty fractions of 20 drops 
each were collected, aliquots of each fraction 
dissolved in 4 ml Rialuma and 14C measured in a 
Nuclear Chicago Isocap 300 scintillation counter. 
Albumin (0.92 mg/ml), LDL (0.93 mg/ml) and 
HDL (0.63 mg/ml) were incubated in sterile 
capped tubes (Corning, Avon Cedex) at 37°C with 
100 mM glucose buffered to pH 7.4 with PBS. All 
solutions were sterile filtered and 1 mM NaNs was 
added as preservative. Samples were removed at 
timed intervals and dialysed at 4°C against several 
changes of PBS over 2-3 days. Aliquots from 
these samples were measured for r4C as in [7]. 
Bovine serum albumin was used for all ex- 
periments presented here, however human serum 
albumin was found to incorporate glucose at an 
identical rate (not shown). 
After incubation with untreated or purified 
glucose, protein samples were prepared as in [7] 
for amino acid analysis [15]. Albumin concentra- 
tions were measured as in [16] relative to an 
albumin standard. The apolipoproteins were quan- 
titated from their amino acid analyses with 
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reference to published compositions for apo B [ 171 
and apo A-l and A-2 [18]. 
3. RESULTS 
[14C]Glucose preparations from either Amer- 
sham or CEA were resolved by HPLC into similar 
patterns, as illustrated in fig. 1 for batch 116 from 
Amersham. The [14C]glucose peak eluted at 
11 min and was preceded by two other peaks at 4 
and 9 min. The proportions of these contaminant 
peaks to that of glucose ranged from 1.5 to 15% 
between individual commercial preparations of 
[14C]glucose but were consistent for a given batch. 
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Fig. 1. HPLC of [‘4C]glucose on a 4 x 250 mm column 
of Lichrosorb NH2. 200&i [‘4C]glucose (batch 116, 
Amersham) was dissolved in 204 water, loaded and 
eluted with acetonitrile : water (80: 20, v/v) at a flow rate 
of 1.5 ml/mm Fractions of 20 drops each were collected 
and 5-,ul aliquots taken for 14C analysis. An expanded 
scale is included (cpm x 10m4, A---A) to show more 
clearly the elution of the two contaminant peaks centred 
on fractions 12 and 25 relative to glucose on fraction 3 1. 
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These differences between batches were not 
necessarily related directly to the age of the 
samples. This was illustrated by the analyses of 
batches 105, 111, 116, 163 produced in March 
1978, November 1978, February 1979 and June 
1983, respectively, by Amersham. Although listed 
as 99,98,99 and 99% radiochemically pure at time 
of production, respectively, they contained 15, 2, 
4 and lS%, respectively, of 14C-labelled con- 
taminants, when measured in December 1983. 
However, time-dependent accumulation of 
radiolysis products is to be expected [19]. When 
repurified [14C]glucose (1 mCi/ml) was stored 
either at 20°C in 3% (v/v) ethanol in water, or at 
4°C in the same solution plus gentamycin (O.Ol%, 
w/v), it was found that although the samples were 
stable for up to 1 month in either of the above con- 
ditions, longer storage resulted in reappearance of 
fast reacting 14C-labelled compounds (not shown). 
Thus, for the glucosylation experiments below, 
[t4C]glucose was freshly purified before each in- 
cubation with protein. 
The courses of nonenzymatic glucosylation of 
albumin, LDL and HDL were followed using 
either the untreated or purified [14C]glucose tracer 
in a 100 mM glucose solution buffered to pH 7.4 
with PBS. The incorporation of trichloroacetic 
acid-precipitable glucose is plotted as a function of 
time in fig.2. The initial reaction rates of the un- 
treated glucose were consistently 16-20-times 
higher than that of the HPLC-purified sugar. The 
result shown here was obtained with batch 116 
from Amersham which had 4% 14C-labelled con- 
taminants. Similar results were obtained with 
batch 91-1279 (CEA) with 6% 14C-labelled 
contaminants. 
Albumin bound purified glucose linearly for 16 
days. Both HDL and LDL showed a more rapid in- 
corporation of purified glucose for the first 3 days. 
This was followed by declining incorporation over 
the following 13 days in the case of HDL and by 
a slower but linear rate than initially for LDL. 
The initial rates of glucosylation by either un- 
treated or purified [‘4C]glucose were calculated as 
mol glucose incorporated after 24 h per mol pro- 
tein and/or per mol lysine (table 1). HDL was 
modified by purified glucose at twice the rate of 
LDL or albumin when expressed per mol lysine. 
However, because of its much greater size 
(550 kDa) apo B or LDL bound 6-times as much 
T~mchys 
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Fig.2. Incorporation of 14C into protein from untreated 
(ti) and purified (o----o) [14C]glucose as a function 
of time. (A) Albumin (13SyM), (B) HDL (17.6rM) 
and (C) LDL (1.7 ,uM) were incubated in 100 mM 
[14C]glucose (spec. act. 240 dpm/nmol) at 37°C. Data 
points show trichloroacetic acid-precipitable 14C in 50-111 
aliquots of incubation solutions. Insets have expanded 
scale on ordinate axis to show more clearly 
incorporation of purified [14C]glucose into protein over 
the first 5 days. 
glucose on a molar basis relative to albumin 
(68 kDa) and 4-times more glucose relative to apo 
Al (27 kDa) and A2 (7.8 kDa) of HDL. These dif- 
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Table 1 
Initial rates of [14C]glucose incorporation 
Untreated [‘4C]glucose Purified [‘4C]glucose 
A B A B 
Albumin 71.2 1.19 4.32 72.0 
HDL 50.3 19.6 3.27 125.0 
LDL 932.0 2389 25.83 66.2 
(A) 10m3 mol Glc*molI’ proteinsday-‘.mM-’ Glc, (B) 1O-6 mol 
Glc.mol-’ Lys.day-’ .rnM-r Glc 
F KH R NaOH 
J&h & 1 
Glc-Lys 
44 
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Fig.3. Amino acid analysis of albumin glucosylated with 
untreated (A) and purified (B) [r4C]glucose. Fractions of 
0.7 ml were collected. Elution positions of the 
glucitollysine peaks (GlcLys, shaded) are shown relative 
to a number of amino acids (single letter code). The void 
volume (I’,) and 0.2 M NaOH regeneration step are also 
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indicated. 
ferences were not discernible with untreated 
glucose (table 1). 
To compare the specificity of the reaction bet- 
ween either pure or impure [‘4C]glucose and pro- 
tein, aliquots of the dialysed albumin solution 
from day 9 of the incubations were reduced to con- 
vert fructosyllysine into the stable glucitollysine, 
hydrolysed and then applied to an amino acid 
analyser. The normal elution program was adapted 
to allow the characteristic [I] double peaks of the 
glucitollysine standard to elute clearly between 
phenylalanine and lysine (fig.3). The hydrolysate 
of albumin incubated with the impure [14C]glucose 
showed a broad distribution of the incorporated 
radioactivity (fig.3a). In contrast, the major 14C 
peaks derived from the reaction between purified 
[‘4C]glucose and albumin coincided with those of 
the glucitollysine standard (fig.3b). The remainder 
of the i4C-labelled material eluted primarily in the 
void volume and probably represents acid- 
degraded glucitollysine. 
4. DISCUSSION 
The presence of minor radioactive impurities, 
either from manufacture or radiolysis products of 
storage, would appear to be inevitable in most 
radiochemical preparations. Although often not of 
concern, these minor contaminants can assume 
major importance when the reaction being traced 
consumes only a few percent of the substrate. 
Nonenzymatic glucosylation is such a reaction. 
Thus, a method which enables radiolabelled 
glucose preparations to be easily and promptly 
repurified is necessary. The HPLC method 
presented fulfills these requirements. The rates of 
reaction of [14C]glucose with protein, from batches 
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repurified at different times, was found to be 
reproducible. The specificity of the reaction bet- 
ween the repurified [‘4C]glucose and the lysine 6- 
amino groups of albumin is clearly demonstrated 
in fig.3. However, only about half of the 
[ *4C]glucose precipitable with trichloroacetic acid 
could be recovered as glucitollysine, indicating that 
as much as 5OQ?o f the bound [‘4C]glucose was 
degraded under the protein hydrolysis conditions 
employed. 
Even after 3 days radioactivity from the un- 
treated [ *4C]glucose was still incorporated 6-fold 
more rapidly into protein than the purified 
glucose. This is the maximum time normally used 
for adsorptive removal of contaminants by pro- 
tein, which in turn illustrates that glucose purified 
by prein~ubation with albumin is probably un- 
satisfactory. The reactions of the untreated and the 
purified [t4C]glucose approached similar rates only 
after 10 days incubation with albumin. With the 
lipoproteins the rate of i4C incorporation was still 
4-times higher for the nonpurified glucose after 16 
days (fig.2). 
The in vitro rates of glucosylation obtained with 
the purified [‘4C]glucose were used to estimate 
glucosylation in vivo. Thus, plasma half-lives of 18 
days for albumin [ 121 and 5 days each for LDL and 
HDL [20,21] would lead to 0.40, 0.65 and 
0.08 mol glucose per mol protein at normal plasma 
levels of glucose and protein. The predicted values 
are within the range of the very preliminary data 
reported for albumin [l,S] and LDL [4] from 
euglycemic individuals of 0.1-0.7 and 0.5 mol 
glucose per mol protein, respectively. The range of 
l.l-3.8% glucosylated lysines reported for HDL 
[5] for 6 euglycemic subjects is above the values of 
0.3% calculable from table 1. Although these 
results were presented as preliminary IS], thus 
precluding a detailed comparison, the 4-12-fold 
difference would require the lysines of HDL to be 
S-24-times more reactive than those of albumin or 
LDL (table 1). 
In addition, repurified [14C]glucose can now 
serve as a specific label to identify susceptible 
glucosylation sites or to synthesise protein stan- 
dards for which the absolute level of glucosylation 
can be measured. Exploration of potential 
Maillard reactions of the non-enzymatically 
glucosylated protein, suggested to be involved in 
the complications of diabetes [l] will also become 
possible. 
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